All-Oral Treatment With Daclatasvir (DCV) Plus Sofosbuvir (SOF) Plus Ribavirin (RBV) for 12 or 16 Weeks in HCV Genotype (GT) 3-Infected Patients With Advanced Fibrosis or Cirrhosis: The ALLY-3+Phase 3 Study

被引：0
|
作者：
Leroy, Vincent [1 ]
Angus, Peter W. [2 ]
Bronowicki, Jean-Pierre [3 ,4 ]
Dore, Gregory [5 ,6 ]
Hezode, Christophe [7 ]
Pianko, Stephen [8 ]
Pol, Stanislas [9 ]
Stuart, Katherine A. [10 ]
Tse, Edmund [11 ]
McPhee, Fiona [12 ]
Bhore, Rafia [13 ]
Exposito, Maria Jesus Jimenez [13 ]
Thompson, Alex J. [5 ,6 ]
机构：
[1] CHU Grenoble, La Tronche, France
[2] Austin Hosp, Heidelberg, Vic 3084, Australia
[3] CHU Nancy, Nancy, France
[4] Lorraine Univ, Nancy, France
[5] St Vincents Hosp, Sydney, NSW 2010, Australia
[6] Kirby Inst, Sydney, NSW, Australia
[7] CHU Henri Mondor, F-94010 Creteil, France
[8] Monash Med Ctr, Clayton, SA, Australia
[9] Hop Cochin, F-75674 Paris, France
[10] Gallipoli Med Res Fdn, Greenslopes, Qld, Australia
[11] Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[12] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[13] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
HEPATOLOGY | 2015年 / 62卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LB-3
引用
收藏
页码：1380A / 1381A
页数：2
相关论文
共 50 条
  • [1] ALL-ORAL TREATMENT WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN IN HCV GENOTYPE 3-INFECTED PATIENTS WITH ADVANCED FIBROSIS OR CIRRHOSIS: AN ANALYSIS OF ALLY-3 AND ALLY-3+
    Kowdley, K.
    Angus, P.
    Bernstein, D.
    Bronowicki, J. -P.
    Leroy, V.
    Pockros, P.
    Bhore, R.
    Rana, K.
    Jimenez-Exposito, M. J.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S789 - S790
  • [2] All-Oral Treatment With Daclatasvir Plus Sofosbuvir ± Ribavirin in HCV Genotype 3-Infected Patients With Advanced Fibrosis or Cirrhosis: An Analysis of ALLY-3 and ALLY-3+
    Kowdley, Kris V.
    Angus, Peter
    Bernstein, David
    Bronowicki, Jean-Pierre
    Leroy, Vincent
    Pockros, Paul J.
    Bhore, Rafia
    Rana, Khurram
    Jimenez-Exposito, Maria Jesus
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S1094 - S1094
  • [3] All-oral 12-week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Patients Infected with HCV Genotype (GT) 3: ALLY-3 Phase 3 Study
    Nelson, David R.
    Cooper, James N.
    Lalezari, Jacob P.
    Lawitz, Eric
    Pockros, Paul J.
    Gitlin, Norman
    Freilich, Bradley
    Younes, Ziad
    Harlan, William
    Ghalib, Reem H.
    Oguchi, Godson I.
    Thuluvath, Paul J.
    Ortiz-Lasanta, Grisell
    Rabinovitz, Mordechai
    Bernstein, David
    Bennett, Michael
    Hawkins, Trevor
    Ravendhran, Natarajan
    Sheikh, Aasim M.
    Varunok, Peter
    Kowdley, Kris V.
    Hennicken, Delphine
    McPhee, Fiona
    Rana, Khurram
    Hughes, Eric A.
    [J]. HEPATOLOGY, 2014, 60 (06) : 1268A - 1269A
  • [4] All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study
    Nelson, David
    Bernstein, David
    Freilich, Bradley
    Lawitz, Eric
    Hawkins, Trevor
    Pockros, Paul J.
    Thuluvath, Paul J.
    Younes, Ziad H.
    Bennett, Michael
    Ghalib, Reem
    Ruane, Peter J.
    Tong, Myron J.
    Bhore, Rafia
    Yin, Philip D.
    Noviello, Stephanie
    Rana, Khurram
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S1003 - S1003
  • [5] ALL-ORAL 12-WEEK COMBINATION TREATMENT WITH DACLATASVIR (DCV) AND SOFOSBUVIR (SOF) IN TREATMENT-EXPERIENCED PATIENTS INFECTED WITH HCV GENOTYPE (GT) 3: A SUBANALYSIS OF THE ALLY-3 PHASE 3 STUDY
    Nelson, D.
    Bernstein, D.
    Freilich, B.
    Lawitz, E.
    Hawkins, T.
    Pockros, P.
    Thuluvath, P.
    Younes, Z.
    Bennett, M.
    Ghalib, R.
    Ruane, P. J.
    Tong, M.
    Bhore, R.
    Yin, P. D.
    Noviello, S.
    Rana, K.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S624 - S624
  • [6] DACLATASVIR PLUS SOFOSBUVIR PLUS RIBAVIRIN FOR 12 OR 16 WEEKS IN TREATMENT-EXPERIENCED PATIENTS WITH HCV GENOTYPE 3 INFECTION AND ADVANCED FIBROSIS OR CIRRHOSIS
    Hezode, C.
    Dore, G.
    Pianko, S.
    Pol, S.
    Stuart, K.
    Thompson, A.
    Tse, E.
    Bhore, R.
    Jimenez-Exposito, M. J.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S753 - S754
  • [7] Daclatasvir Plus Sofosbuvir Plus Ribavirin for 12 or 16 Weeks in Treatment-Experienced Patients With HCV Genotype 3 Infection and Advanced Fibrosis or Cirrhosis
    Hezode, Christophe
    Dore, Gregory J.
    Pianko, Stephen
    Pol, Stanislas
    Stuart, Katherine
    Thompson, Alexander
    Tse, Edmund
    Bhore, Rafia
    Jimenez-Exposito, Maria Jesus
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S1096 - S1096
  • [8] Daclatasvir Plus Sofosbuvir Plus RIbavirin in HCV Genotype 3 Infected Patients with Cirrhosis Child A: A Randomized Trial for 16 or 24 Weeks (NCT #02304159)
    Hassanein, Tarek I.
    Esshaki, Yasmeen
    Hill, Catherine
    Pozza, Renee
    Higham, Jennifer
    Luvisa, B. K.
    Hefner, Anna Marie
    [J]. HEPATOLOGY, 2016, 64 : 450A - 450A
  • [9] All-oral 12-week treatment with daclatasvir and sofosbuvir in treatment-experienced patients infected with HCV genotype 3: a subanalysis of the ALLY-3 phase 3 study
    Nelson, D.
    Bernstein, D.
    Freilich, B.
    Lawitz, E.
    Hawkins, T.
    Pockros, P.
    Thuluvath, P.
    Younes, Z.
    Bennett, M.
    Ghalib, R.
    Peter, R.
    Tong, M.
    Bhore, R.
    Yin, P.
    Noviello, S.
    Rana, K.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 30 - 30
  • [10] Daclatasvir (DCV) plus Sofosbuvir (SOF) regimens in chronic Hepatitis C Virus (HCV) infected patients with advanced fibrosis or cirrhosis
    Elefsiniotis, Loannis S.
    Dalekos, George N.
    Koskinas, John
    Ioannidou, Panagiota
    Cholongitas, Evangelos
    Manolakopoulos, Spilios
    Goulis, John
    Vlachogiannakos, John
    Deutsch, Melani
    Triantos, Christos K.
    Kapatais, Andreas
    Sevastianos, Vassilios A.
    Schina, Maria J.
    Karatapanis, Stylianos
    Ketikoglou, Loannis
    Manesis, Emanuel K.
    Papageorgiou, Maria-Vasiliki
    Sinakos, Emanuel
    Gatselis, Nikolaos K.
    Karagiannakis, Dimitrios
    Tasovasili, Athanasia
    Koukoufiki, Argyro
    Voulgaris, Theodoros A.
    Tsolias, Chrysostomos
    Akriviadis, Evangelos
    Papatheodoridis, George V.
    [J]. HEPATOLOGY, 2016, 64 : 990A - 991A
12345